Benoît Mukinayi Mbiya has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Low-Abundance and Fragmentary Helicobacter pylori DNA Detected in Phenotypically Negative Gastric Biopsies Using Targeted Sequencing

    by Fabien Mbaya-Tshibangu, Alain Cimuanga-Mukanya, Evariste Tshibangu-Kabamba, Nadine Kayiba-Kalenda, Tressy Kalenga-Ngomba, Patrick de Jesus Ngoma-Kisoko, Gunturu Revathi, Junko Akada, Benoît Mbiya-Mukinayi, Augustin Tshibaka Kabongo, et al.

    Accurate detection and monitoring of antimicrobial resistance (AMR) in Helicobacter pylori mainly rely on phenotypic methods and culture, which can sometimes fail when bacterial load is low or after recent treatment. We investigated whether gastric biopsies classified as H. pylori-negative by standard diagnostic techniques still contain detectable bacterial DNA, including regions linked to AMR, and assessed whether selected DNA fragments can mediate allelic exchange in vitro. Gastric biopsies from 46 dyspeptic patients in the Democratic Republic of the Congo (including 23 phenotypically positive and 23 phenotypically negative individuals) were analyzed using long-read amplicon sequencing of seven resistance-associated loci, selective whole-genome amplification (sWGA) followed by long-read sequencing of H. pylori-enriched reads, and a proof-of-concept natural transformation assay. Phenotypically negative biopsies exhibited significantly lower sequencing depth across multiple loci (including 23S rRNA, gyrA, gyrB, and pbp1A; p = 0.003–0.014), indicating a reduced H. pylori DNA burden. However, AMR-associated mutations linked to various antibiotic classes were found in both groups. sWGA enabled recovery of fragmentary H. pylori sequence data from phenotypically negative samples, including reads that map to resistance- and virulence-associated genes. In vitro, 23S rRNA A2143G amplicons from both phenotypically positive and negative biopsies produced clarithromycin-resistant transformants in strain 26695. These findings indicate that phenotypically negative gastric biopsies might contain low-abundance and fragmentary H. pylori DNA. Although certain DNA fragments can mediate allelic exchange under controlled in vitro conditions, these results do not confirm bacterial viability, active infection, or clinically relevant in vivo resistance transfer. Therefore, they should be interpreted with caution in molecular AMR surveillance and detection contexts.

  • Open Access

    Assessing the quality of life of adolescents with sickle cell disease and their transition to adult medicine: experience in a remote area of the Democratic Republic of Congo

    by Benoît Mbiya-Mukinayi, Corneille Kalala-Mushinta, Schadrac Kalombo-Munganga, Alexandre Kalala-Mwanza, Steve Kasongo-Tshiala, John Mpoyi-Kalenda, Béatrice Gulbis

  • Open Access

    Managing of acute pediatric cough in Africa: prescription of cough suppressants and associated complications

    by Benoît Mbiya-Mukinayi, Denis Mbuyi-Kalambayi, Steve Kasongo-Tshiala, Valery Daubie

    INTRODUCTION: The use of antitussives is a crucial issue in pediatrics and can lead to respiratory complications that can affect the prognosis. The objective of this study is to determine the frequency of respiratory complications associated with the use of antitussives in pediatrics in a remote city in the Democratic Republic of Congo. METHODS: this is a cross-sectional retrospective study conducted between January 1, 2017, and December 2022. Patients under 12 years of age with an acute cough were eligible. The parameters studied were treatment with cough suppressants and associated respiratory complications. RESULTS: a total of 218 children suffered from an acute cough. The average age was 11 months 10, and the sex ratio (H/F) was 126/92. In 30% of cases, children were treated with cough suppressants for an average of 7 days before admission. Respiratory complications were observed in 11% (23/218) of cases. For most of these complications, 61% (14 of 23), had received antitussive treatment before hospitalization. Respiratory complications were associated with cough medications (p-value = 0.0012, relative risk (RR) = 3.66, IC90 [1.696; 7,873]). Acute respiratory distress was reported in 87% (20/23) of cases and was associated with the use of cough suppressants (p-value = 0.0065, RR: 3.060, IC90: [1.433; 6,485]). CONCLUSION: the use of antitussives in pediatrics poses a risk of acute respiratory distress in a remote city that does not have sufficient human and material resources for management.


  • Open Access

    Managing of Acute Pediatric Cough in Africa: prescription of Cough Suppressants and Associated Complications

    by Benoît Mukinayi Mbiya, Denis Kalambayi Mbuyi, Steve Tshiala Kasongo, Valery Daubie

    Background: The use of antitussives is a crucial issue in pediatrics and can lead to respiratory complications that can affect the prognosis. Objectives: to determine the frequency of respiratory complications associated with the use of an-titussives in pediatrics in a remote city in the Democratic Republic of Congo. Method: This is a cross-sectional retrospective study conducted between January 1, 2017 and De-cember 2022. Patients under 12 years of age with an acute cough were eligible. The parameters studied were treatment with cough suppressants and associated respiratory complications. Results: A total of 218 children suffered from an acute cough. The average age was 11 months 10, the sex ratio (H/F) was 126/92. In 30% of cases, children were treated with cough suppressants for an average of 7 days prior to admission. Respiratory complications were observed in 11% (23/218) of cases. The majority of these complications, 61% (14 of 23), had received antitussive treatment prior to hospitalization. Respiratory complications were associated with cough medications (p-value = 0.0012, relative risk (RR) = 3.66, IC90 [1.696; 7,873]). Acute respiratory distress was reported in 87% (20/23) of cases and was associated with the use of cough suppressants (p-value = 0.0065, RR: 3.060, IC90: [1.433; 6,485]). Conclusion: The use of antitussives in pediatrics poses a risk of acute respiratory distress in a remote city that does not have sufficient human and material resources for management. Keywords: cough, cough suppressants, pediatrics, complications, Mbujimayi, Democratic Republic of Congo.

  • Open Access

    Gen Z and HIV—Strategies for Optimizing the Care of the Next Generation of Adolescents Living with HIV

    by Inès Dufour, Yves Fougère, Tessa Goetghebuer, Marc Hainaut, Benoît Mbiya, Fatima Kakkar, Jean Cyr Yombi, Dimitri Van der Linden

    The management of adolescents living with HIV represents a particular challenge in the global response to HIV. The challenges specific to this age group include difficulties engaging and maintaining them in care, challenges with transition to adult care, and limited therapeutic options for treatment-experienced patients, all of which have been jeopardized by the COVID-19 pandemic. This paper summarizes some of the challenges in managing adolescents living with HIV, as well as some of the most recent and innovative therapeutic approaches in this population.


  • Open Access

    Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report

    by Benoît Mbiya Mukinayi, John Mpoyi Kalenda, Didier Kalombo Kalenda, Ghislain Disashi Tumba, Béatrice Gulbis

    Background: Sickle cell disease and oculocutaneous albinism are rare autosomal recessive disorders both related to mutations on chromosome 11. The diagnosis of patients suffering from both pathologies is necessary to enable dedicated monitoring of any complications at the ophthalmic and skin level. However, few cases are described in the literature.Case presentation: A 14-month-old Congolese male child affected by oculocutaneous albinism, presented with pallor and jaundice. Blood indices revealed severe hemolytic anemia, which led to the diagnosis of sickle cell disease. The patient received a blood transfusion and close follow-up.Conclusions: The co-inheritance of sickle cell disease and oculocutaneous albinism is a reality in the Democratic Republic of Congo, although it is rarely described. Given the current state of our knowledge, specific surveillance, specifically regarding cutaneous and ophthalmological complications, should be offered in this particular population. To enable this dedicated follow-up, sensitization to screening for sickle cell anemia in albino individuals should be carried out.


  • Open Access

    Drépanocytose en République Démocratique du Congo: quels sont les obstacles à un traitement par hydroxyurée?

    by Benoît Mbiya Mukinayi, Guelord Kalombo Cibeyibeyi, Ghislain Disashi Tumba, Béatrice Gulbis

    INTRODUCTION: L´hydroxyurée est le seul produit dont l´efficacité a été prouvée pour prévenir les complications de la drépanocytose et approuvé par la Food and Drug Administration. Pour pouvoir offrir ce traitement aux patients atteints de drépanocytose, il doit être prescrit, disponible et à un prix abordable. L´objectif de cette étude est de déterminer la disponibilité et le coût de l´hydroxyurée sur le marché en République démocratique du Congo et comparer les deux aspects entre une ville reculée, à savoir Mbujimayi, et une grande ville, à savoir, Lubumbashi. METHODES: il s´agit d´une étude transversale réalisée dans le cadre d´une enquête face-à-face menée du 1er avril au 1er septembre 2017 auprès de 188 pharmacies congolaises. RESULTATS: hydroxyurée était disponible dans 41/188 (22%) pharmacies participantes, mais plus fréquemment dans celles d´une grande ville que dans celles d´une ville reculée (34/96 contre 7/92). La plupart des patients ont reçu une ordonnance médicale (36/41; 88%). Le prix moyen de l´hydroxyurée était de 15 $ (10 $ à 35 $) pour une boîte de 25 gélules; ce prix est supérieur au pouvoir d´achat de la majorité des patients drépanocytaires. L´hydroxyurée reste encore un produit importé de l´Europe, des États-Unis ou d´Asie. CONCLUSION: l´hydroxyurée est l´un des principaux traitements permettant d´améliorer l´évolution de la maladie chez les patients drépanocytaires. Néanmoins, en République Démocratique du Congo, sa disponibilité pourrait être améliorée, en particulier dans une ville reculée, et son prix reste trop élevé pour être payé par la population locale.


  • Open Access

    Improvement of Sickle Cell Disease Morbimortality in Children: Experience in a Remote Area of an African Country

    by Benoît Mukinayi Mbiya, Didier Kalenda Kalombo, Yannick Nkesu Mukendi, John Kalenda Mpoyi, Parola Mukendi Biboyi, Valery Daubie, Ghislain Tumba Disashi, Béatrice Gulbis

    Background: Sickle cell disease (SCD) is a public health problem in the Democratic Republic of Congo. While reference sickle cell centers have been implemented in capital cities of African countries and have proven to be beneficial for SCD patients, they have never been set up in rural areas for families with very low sources of income. Method: A cohort of 143 children with SCD aged 10 years old (IQR (interquartile range): 6–15 years) (sex ratio male/female = 1.3) were clinically followed for 12 months without any specific intervention aside from the management of acute events, and then for 12 months with a monthly medical visit, biological follow-up, and regular prophylaxis. Results: The median age of patients at the diagnosis of SCD was 2 years (IQR: 1–5). The implementation of standardized and regular follow-ups in a new sickle cell referral center in a remote city showed an increase in the annual mean hemoglobin level from 50 to 70 g/L (p = 0.001), and a decrease in the lymphocyte count and spleen size (p < 0.001). A significant decrease (p < 0.001) in the average annual number of hospitalizations and episodes of vaso-occlusive crises, blood transfusions, infections, and acute chest syndromes were also observed. Conclusions: Creation of a sickle cell referral center and the regular follow-up of children with SCD are possible and applicable in the context of a remote city of an African country and represent simple and accessible measures that can reduce the morbimortality of children with sickle cell disease.

  • Open Access

    Improvement of Sickle Cell Disease Morbimortality in Children: Experience in a Remote Area of an African Country

    by Benoît Mukinayi Mbiya, Didier Kalenda Kalombo, Yannick Nkesu Mukendi, Valery Daubie, John Kalenda Mpoyi, Parola Mukendi Biboyi, Ghislain Tumba Disashi, Béatrice Gulbis

    Background: Sickle cell disease (SCD) is a public health problem in the Democratic Republic of Congo. While reference sickle cell centers have been implemented in capital cities of African countries and have proven to be beneficial for SCD patients, they have never been set up in rural areas for families with very low sources of income. Method: A cohort of 143 children with SCD aged 10 years old (IQR (interquartile range): 6–15 years) (sex ratio male/female = 1.3) were clinically followed for 12 months without any specific intervention aside from the management of acute events, and then for 12 months with a monthly medical visit, biological follow-up, and regular prophylaxis. Results: The median age of patients at the diagnosis of SCD was 2 years (IQR: 1–5). The implementation of standardized and regular follow-ups in a new sickle cell referral center in a remote city showed an increase in the annual mean hemoglobin level from 50 to 70 g/L (p = 0.001), and a decrease in the lymphocyte count and spleen size (p < 0.001). A significant decrease (p < 0.001) in the average annual number of hospitalizations and episodes of vaso-occlusive crises, blood transfusions, infections, and acute chest syndromes were also observed. Conclusions: Creation of a sickle cell referral center and the regular follow-up of children with SCD are possible and applicable in the context of a remote city of an African country and represent simple and accessible measures that can reduce the morbimortality of children with sickle cell disease.

  • Open Access

    Sickle Cell Disease in the Democratic Republic of Congo: Assessing Physicians’ Knowledge and Practices

    by Benoît Mukinayi Mbiya, Ghislain Tumba Disashi, Béatrice Gulbis

    Background: Sickle cell disease is a major public health issue in the Democratic Republic of Congo (DRC), but it is still poorly understood by health professionals. The objective of this study was to assess the knowledge and practices of Congolese physicians treating sickle cell disease (SCD), in order to identify the areas for improvement in clinical care. Methods: This was a descriptive observational study conducted among Congolese physicians using a questionnaire. Participants were evaluated using a pre-established answer grid. Results: A total of 460 physicians participated, including 81 women (18%), with an average age of 35 years (range 25–60 years). Most physicians were general practitioners. Although self-assessment of their level of knowledge on SCD was estimated as average to good, less than half of the participants (n = 460; 46%) reported adequate management of vaso-occlusive crises, and only 1% of them had received specific training on SCD. Most physicians reported difficulties both in terms of diagnostic (65%) and management (79%) options of SCD patients. This study also showed that 85% of these physicians did not have access to the diagnostic tools for SCD. Conclusions: Insufficient knowledge on SCD and poor diagnostic and treatment options might contribute to increased morbidity and mortality of patients living in the DRC. Interventions aiming to improve physicians’ knowledge, patient follow-up, and treatment access are needed. Specific training alongside existing programs (HIV, malaria), early diagnosis of the disease, and the creation of patient advocacy groups should be implemented to improve SCD patient care.